1. S-800342
2. Sl 80-0342
1. 82626-01-5
2. Ananxyl
3. 2-(6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide
4. Sl 80.0342-00
5. 6-chloro-2-(p-chlorophenyl)-n,n-dipropylimidazo(1,2-a)pyridine-3-acetamide
6. 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-n,n-dipropylacetamide
7. Chembl54349
8. I93sc245qz
9. Sl-80.0342-00
10. 6-chlor-2-(4-chlorphenyl)-n,n-dipropylimidazol(1,2-a)pyridin-3-acetamid
11. Alpidemum [latin]
12. Ncgc00182850-01
13. Imidazo(1,2-a)pyridine-3-acetamide, 6-chloro-2-(4-chlorophenyl)-n,n-dipropyl-
14. Dsstox_cid_28972
15. Dsstox_rid_83237
16. Dsstox_gsid_49046
17. Alpidemum
18. Cas-82626-01-5
19. Alpidem [usan:inn:ban]
20. Unii-i93sc245qz
21. S-800342
22. Alpidem-[d14]
23. Alpidem (usan/inn)
24. Alpidem [usan]
25. Alpidem [inn]
26. Alpidem [mi]
27. Alpidem [mart.]
28. Alpidem [who-dd]
29. Schembl122619
30. Dtxsid8049046
31. Bdbm22041
32. Chebi:135649
33. Zinc599598
34. Tox21_113593
35. Alpidem, >=98% (hplc), Powder
36. Pdsp1_000633
37. Pdsp2_000628
38. Akos016014168
39. Tox21_113593_1
40. Cs-w013866
41. Hy-w013150
42. Ncgc00182850-02
43. Ft-0630911
44. D02833
45. A930152
46. Sr-01000944944
47. Q4735440
48. Sr-01000944944-1
49. 2-(6-chloro-2-(4-chlorophenyl)h-imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide
Molecular Weight | 404.3 g/mol |
---|---|
Molecular Formula | C21H23Cl2N3O |
XLogP3 | 4.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 7 |
Exact Mass | 403.1218178 g/mol |
Monoisotopic Mass | 403.1218178 g/mol |
Topological Polar Surface Area | 37.6 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 478 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
LOOKING FOR A SUPPLIER?